DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

2 months ago

May 08, 2026 17:00 ET  | Source: DSS, Inc. ROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE…

NVIDIA Names Suzanne Nora Johnson to Board of Directors

2 months ago

SANTA CLARA, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- NVIDIA today announced that it has named to its board of…

SalesCloser Announces Collaboration with Twilio to Accelerate Customer Deployments

2 months ago

Collaboration with Twilio, a leading global cloud communications platform1, aims to streamline enterprise-grade phone number activation, reduce compliance friction, and…

Crypto News Today: AlphaPepe Presale Near Sell-Out While Bitcoin Price Prediction Points To $250k

2 months ago

MONACO, May 08, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as Stage 15 moves toward a…

Crypto News: AlphaPepe Advances Toward Q2 Exchange Listing While XRP Price Prediction Targets $10

2 months ago

MONACO, May 08, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe as the project advances toward its Q2…

FormFactor to Ring the Nasdaq Stock Market Closing Bell on May 11th, 2026

2 months ago

May 08, 2026 18:11 ET  | Source: FormFactor, Inc. LIVERMORE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ:…

James Cacioppo Files Updated Early Warning Report

2 months ago

May 08, 2026 16:05 ET  | Source: Jushi Holdings Inc. BOCA RATON, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- James…

Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held on June 10, 2026

2 months ago

REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter…

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

2 months ago

MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular…

AAVnerGene Announces AAVone2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest

2 months ago

ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution…